# Passage BIO, Inc.: Form SC 13D/A, filed Apr 12, 2024

- Company: [Passage BIO, Inc.](/companies/pasg.md) (CIK 1787297)
- Form: SC 13D/A
- Filed: 2024-04-12
- Accepted by EDGAR: Apr 12, 2024, 17:35 ET
- Period: not reported
- Accession: 0000947871-24-000373
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1787297/000094787124000373/ss3259632_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1787297/000094787124000373/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1787297/000094787124000373/ss3259632_sc13da.htm

Filed Apr 12, 2024.
Source: SEC EDGAR, the filing index for accession 0000947871-24-000373. Last ingested by Listed: Nov 10, 2026, 16:52 ET. No prices; not investment advice.
